Clinical Trial Update: Fructose is a Metabolic and Inflammatory Pathogenic Factor in Metabolic Dysfunction-associated Steatohepatitis (MASH) [NA]

View source ↗

Summary

A clinical trial at Queen Mary University of London is examining fructose as a metabolic and inflammatory factor in metabolic dysfunction-associated steatohepat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Steatosis
• Metabolic Dysfunction-associated Steatohepatitis
• Metabolic Dysfunction-associated Steatohepatitis with Fibrosis

Snippet

Sponsor: Queen Mary University of London | Conditions: MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis | NA | Status: RECRUITING